TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler, Daniel R. Getts, Adam C. Bledsoe, Glennda Smithson, M. Roy First, Amy Morris, Michael S. Boyne, Adam Elhofy, Tsung‐Teh Wu, Joseph R. Podojil, Stephen D. Miller, Robert Fogel, Tobias Freitag, Michele Gerber, Paul K. Haynes, Michael Koren, Mark Matson, Seppo Meri, Thomas H. Oliphant, Barbara Rizzardi, Jocelyn A. Silvester, Mark S. Turner
Topics & Concepts
MedicinePlaceboGastroenterologyEnteropathyInternal medicineGlutenIntraepithelial lymphocyteCD8Clinical endpointAdverse effectTolerabilityImmunologyImmune systemRandomized controlled trialDiseasePathologyAlternative medicineCeliac Disease Research and ManagementMicroscopic ColitisLiver Diseases and Immunity